Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58.2Revenue (TTM) $M165Net Margin (%)-106.6Altman Z-Score-3.1
Enterprise Value $M300EPS (TTM) $-6.0Operating Margin %-88.5Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.9Pre-tax Margin (%)-105.6Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.45-y EBITDA Growth Rate %-12.1Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-43.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-281.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.6ROIC % (ttm)-53.8Gross Margin Increase y-yN

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRJohn Paulson 2016-03-31 Sold Out $3.48 - $10.1
($6.27)
$ 1.97-69%Sold Out0
AEGRJohn Paulson 2015-12-31 Buy $8.95 - $16.36
($11.97)
$ 1.97-84%New holding26,400
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 1.97-92%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 1.97-92%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 1.97-92%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 1.97-94%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 1.97-94%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 1.97-97%New holding200,000
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 1.97-86%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 1.97-89%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Broadfin Healthcare Master Fun10% Owner 2016-09-13Buy75,000$1.7512.57view
Broadfin Healthcare Master Fun10% Owner 2016-09-12Buy276,000$1.6618.67view
Broadfin Healthcare Master Fun10% Owner 2015-11-11Buy40,100$10.96-82.03view
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-93.57view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-94.15view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-93.46view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-93.76view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-93.55view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-94.42view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-94.17view

Quarterly/Annual Reports about AEGR:

News about AEGR:

Articles On GuruFocus.com
Stocks Reach 5-Year Lows Apr 11 2016 
Stocks Reach 5-year Lows Apr 04 2016 
Stocks Fall to 5-Year Lows Mar 28 2016 
Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
Three CEOs Reporting Large Insider Buys May 22 2014 
Four CEOs Reporting Large Insider Buys May 09 2014 
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 

More From Other Websites
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 29 2016
Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to... Nov 29 2016
Aegerion's Juxtapid Gets Pricing Authorization in Japan Nov 18 2016
Aegerion Pharmaceuticals' JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial... Nov 17 2016
Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous... Nov 17 2016
AEGERION PHARMACEUTICALS, INC. Financials Nov 11 2016
ETF’s with exposure to Aegerion Pharmaceuticals, Inc. : November 8, 2016 Nov 08 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Nov 07 2016
Aegerion Pharmaceuticals, Inc. :AEGR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7,... Nov 07 2016
Aegerion Pharmaceuticals Appoints John Orloff, M.D., as Executive Vice President, Head of R&D Nov 04 2016
Aegerion (AEGR) Reports Narrower-than-Expected Loss in Q3 Nov 04 2016
Aegerion reports 3Q loss Nov 03 2016
Aegerion reports 3Q loss Nov 03 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 03 2016
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results Nov 03 2016
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results Nov 03 2016
QLT's (QLTI) Reports In-Line Q3 Loss, Merger in Focus Nov 02 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Oct 24 2016
ETF’s with exposure to Aegerion Pharmaceuticals, Inc. : October 20, 2016 Oct 20 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Oct 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)